The AXIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AXIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AXIM Detailed Price Forecast - CNN Money||View AXIM Detailed Summary - Google Finance|
|View AXIM Detailed Summary - Yahoo! Finance||View AXIM Stock Research & Analysis - Zacks.com|
|View AXIM Trends & Analysis - Trade-Ideas||View AXIM Major Holders - Barrons|
|View AXIM Call Transcripts - NASDAQ||View AXIM Breaking News & Analysis - Seeking Alpha|
|View AXIM Annual Report - CompanySpotlight.com||View AXIM OTC Short Report - OTCShortReport.com|
|View AXIM Fundamentals - TradeKing||View AXIM SEC Filings - Bar Chart|
|View Historical Prices for AXIM - The WSJ||View Performance/Total Return for AXIM - Morningstar|
|View the Analyst Estimates for AXIM - MarketWatch||View the Earnings History for AXIM - CNBC|
|View the AXIM Earnings - StockMarketWatch||View AXIM Buy or Sell Recommendations - MacroAxis|
|View the AXIM Bullish Patterns - American Bulls||View AXIM Short Pain Metrics - ShortPainBot.com|
|View AXIM Stock Mentions - StockTwits||View AXIM Stock Mentions - PennyStockTweets|
|View AXIM Stock Mentions - Twitter||View AXIM Investment Forum News - Investor Hub|
|View AXIM Stock Mentions - Yahoo! Message Board||View AXIM Stock Mentions - Seeking Alpha|
|View Insider Transactions for AXIM - SECform4.com||View Insider Transactions for AXIM - Insider Cow|
|View AXIM Major Holdings Summary - CNBC||View Insider Disclosure for AXIM - OTC Markets|
|View Insider Transactions for AXIM - Yahoo! Finance||View Institutional Holdings for AXIM - NASDAQ|
|View AXIM Stock Insight & Charts - FinViz.com||View AXIM Investment Charts - StockCharts.com|
|View AXIM Stock Overview & Charts - BarChart||View AXIM User Generated Charts - Trading View|
AXIM® Biotechnologies Announces Cultivation Agreement to Establish Company’s First Domestic Industrial Hemp Source & Begins Harvesting
Posted on Tuesday September 17, 2019
(“AXIM® Biotech,” “AXIM” or “the Company”) (AXIM), a world leader in cannabinoid research and development, today announced that it has signed a cultivation agreement with a top hemp farm in North Carolina to establish the Company’s first domestic industrial hemp source.
The Week In Cannabis: Big Pharma Makes Moves, Diddy & Wahlberg Go After CBD, Medicine Man Continues M&A Spree
Posted on Friday September 13, 2019
This week, we saw Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) make a big move in the cannabis industry, through a distribution deal between its subsidiary Salomon, Levin, Elstein, and InterCure Ltd ...
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies
Posted on Thursday September 12, 2019
SAN DIEGO , Sept. 12, 2019 /PRNewswire/ -- Medical Marijuana, Inc . (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...
Axim® Biotechnologies Begins Manufacturing Cannabinoid-Based Gum With Dronabinol for Use in Upcoming Pre-Clinical Studies
Posted on Tuesday September 10, 2019
(“AXIM® Biotech,” “AXIM” or “the Company”) (AXIM), a world leader in cannabinoid research and development, announced today that its contract manufacturer Eurofins Amatsigroup has begun manufacturing AXIM’s patented cannabinoid-based chewing gum with dronabinol, a synthetic form of tetrahydrocannabinol (THC), for use in the Company’s upcoming clinical studies on cannabis as a treatment for chemotherapy related symptoms. According to the Center of Disease Control and Prevention (CDC), about 650,000 cancer patients in the U.S. receive chemotherapy in an outpatient oncology clinic each year with an average cost of $100,000 per patient per year. Chemotherapy has been proven to be an effective treatment to kill cancer cells but in the process causes damage to other cells and tissues in the body.